Be part of the knowledge - AXISMedEd

Medical News

Medical News
Radiation Therapy May Be Potential Heart Failure Treatment
medicine.wustl.edu
12/04/2023
Read more
Medical News
Scientists Find Gene Therapy Reduces Liver Cancer in Animal Model
medicalxpress.com
12/04/2023
Read more
Medical News
Pennington Receives Nearly $14 Million to Study Childhood Obesity in Rural and Minority Areas
wbrz.com
12/04/2023
Read more
Medical News
BU Researcher Wins NIH Award to Quantify Long-Term Impact of Nutritional Interventions on TB Incidence
news-medical.net
12/04/2023
Read more
Medical News
Moffitt Researchers Identify Cell Signaling Pathway Controlling Melanoma Cell Metastasis to the Brain
newswise.com
12/01/2023
Read more
Medical News
New Study of an AI-Powered Spectroscopy Device Shows Promise for Skin Cancer Detection
businesswire.com
11/30/2023
Read more
Medical News
Threats to Public Health Workers
udel.edu
11/30/2023
Read more
Medical News
Growing Microtumors in a Dish Helps Rapidly Identify Genes That Drive Tumor Growth
today.uic.edu
11/29/2023
Read more

Popular

Lowering Burden to Raise Adherence: Optimizing Prophylaxis for Hemophilia A
Lowering Burden to Raise Adherence: Optimizing Prophylaxis for Hemophilia A
CME/CE
Lowering Burden to Raise Adherence: Optimizing Prophylaxis for Hemophilia A
0.50 credits
- Guy Young, MD
  Peer
0.50 credits
Incorporating Scientific Advances into Myelofibrosis Treatment Plans
Incorporating Scientific Advances into Myelofibrosis Treatment Plans
CME/CE
Incorporating Scientific Advances into Myelofibrosis Treatment Plans
1.00 credit
- Ruben Mesa, MD, FACP
  Peer
1.00 credit
Taking Command of the Treatment of ESA-Refractory, Transfusion-dependent LR-MDS
Taking Command of the Treatment of ESA-Refractory, Transfusion-dependent LR-MDS
CME/CE
Taking Command of the Treatment of ESA-Refractory, Transfusion-dependent LR-MDS
0.25 credits
- Paul P. Doghramji, MD, FAAFP
  Peer
- Rami Komrokji, MD
  Peer
- Allan Platt, PA-C, MMSc
  Peer
0.25 credits
NSCLC Therapy Management and Biomarker Testing
NSCLC Therapy Management and Biomarker Testing
CME/CE Broadcast Replay
NSCLC Therapy Management and Biomarker Testing
1.00 credit
- Mark Socinski, MD
  Peer
1.00 credit
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
CME/CE Broadcast Replay
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
1.00 credit
- Neeraj Agarwal, MD
  Peer
1.00 credit
UsHERing in New Standards of Care on HER2+ and HER2-Low MBC
UsHERing in New Standards of Care on HER2+ and HER2-Low MBC
CME/CE
UsHERing in New Standards of Care on HER2+ and HER2-Low MBC
- Reshma L. Mahtani, DO
  Peer
Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: A Video Viewpoint
Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: A Video Viewpoint
CME/CE
Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: A Video Viewpoint
0.25 credits
- Caron A. Jacobson, MD
  Peer
0.25 credits
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
CME/CE
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
0.25 credits
- Mark Socinski, MD
  Peer
- Patrick Forde, M.B.B.Ch.
  Peer
- Karen Reckamp, MS, MD
  Peer
0.25 credits

CME

Getting on Board with Real-World Evidence About CDK 4/6 Inhibitors for HR+/HER2- mBC: Stay on Track with Shared Decision-Making
Getting on Board with Real-World Evidence About CDK 4/6 Inhibitors for HR+/HER2- mBC: Stay on Track with Shared Decision-Making
CME/CE
Getting on Board with Real-World Evidence About CDK 4/6 Inhibitors for HR+/HER2- mBC: Stay on Track with Shared Decision-Making
0.25 credits
- Richard S. Finn, MD
  Peer
0.25 credits
Advancing Global Care with Emerging BTKi in Relapsed/Refractory CLL: Connecting Hematology Leaders to Worldwide Learners
Advancing Global Care with Emerging BTKi in Relapsed/Refractory CLL: Connecting Hematology Leaders to Worldwide Learners
CME/CE
Advancing Global Care with Emerging BTKi in Relapsed/Refractory CLL: Connecting Hematology Leaders to Worldwide Learners
0.50 credits
- Anthony Mato, MD, MSCE
  Peer
- Toby A. Eyre, MD, MBChB
  Peer
- Talha Munir, PhD
  Peer
0.50 credits
Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: A Video Panel Discussion
Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: A Video Panel Discussion
CME/CE
Paradigm Shifts in CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: A Video Panel Discussion
0.50 credits
- Caron A. Jacobson, MD
  Peer
- Matthew Lunning, DO
  Peer
- Loretta J. Nastoupil, MD
  Peer
0.50 credits